SC209 intermediate-2

• Description:

  SC209 intermediate-2 (Compound A9) is an intermediate of the ADC cytotoxin SC209 (HY-144880) . SC209 intermediate-2 is an ADC Linker[1].

• UNSPSC:

  12352203

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  ADC Payload

• Type:

  ADC Related

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/sc209-intermediate-2.html

• Purity:

  99.60

• Solubility:

  DMSO : 200 mg/mL (ultrasonic)

• Smiles:

  CC(C)(C1=CC(N)=CC=C1)[C@H](N(C)C(OC(C)(C)C)=O)C(N[C@@H](C(C)(C)C)C(N(C)[C@@H](C(C)C)/C=C(C)/C(OCC)=O)=O)=O

• Molecular Formula:

  C34H56N4O6

• Molecular Weight:

  616.83

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Toni Kline, et al. Hemiasterlin derivatives for conjugation and therapy. Patent. WO2016123582.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  ADC Related

• Clinical Information:

  No Development Reported

• CAS Number:

  1977557-83-7